News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
44,239 Results
Type
Article (1483)
Company Profile (5)
Press Release (42751)
Section
Business (15654)
Career Advice (16)
Deals (3133)
Drug Delivery (4)
Drug Development (3987)
Employer Resources (4)
FDA (630)
Job Trends (748)
News (20804)
Policy (1640)
Tag
2027 Genetown Standard (1)
2027 Pharm Country Standard (1)
Academia (112)
Accelerated approval (4)
Allergies (2)
Alliances (3096)
ALS (13)
Alzheimer's disease (135)
Antibody-drug conjugate (ADC) (16)
Approvals (662)
Artificial intelligence (64)
ASCO (14)
Autoimmune disease (19)
Automation (2)
Bankruptcy (23)
Belgium (11)
Best Places to Work (480)
BIO (6)
Biologics (1)
Biosimilars (4)
BioSpace Insights (3)
Biotechnology (17)
Bispecific (1)
Bladder cancer (10)
Brain cancer (6)
Breast cancer (98)
Cancer (420)
Cardiovascular disease (32)
Career advice (17)
Career pathing (1)
CAR-T (7)
CDC (1)
Cell therapy (46)
Clinical research (3374)
Collaboration (152)
Commercialization (1)
Compensation (11)
Complete response letters (1)
COVID-19 (247)
CRISPR (22)
C-suite (91)
Cystic fibrosis (5)
Data (445)
Depression (9)
Dermatology (6)
Diabetes (12)
Diagnostics (654)
Digital health (4)
Diversity (1)
Diversity, equity & inclusion (2)
Drug discovery (33)
Drug pricing (1)
Duchenne muscular dystrophy (17)
Earnings (5198)
Employer resources (3)
ESMO (19)
Events (6113)
Executive appointments (86)
FDA (811)
Fragile X (3)
Friedreich's ataxia (1)
Funding (141)
Gene editing (30)
Generative AI (2)
Gene therapy (16)
GLP-1 (30)
Government (138)
Guidances (18)
Healthcare (1162)
Hematology (3)
HIV (4)
Huntington's disease (4)
IgA nephropathy (2)
Immunology and inflammation (7)
Immuno-oncology (4)
Indications (5)
Infectious disease (261)
Inflammatory bowel disease (5)
Influenza (1)
Intellectual property (11)
Interviews (3)
IPO (1298)
Job creations (278)
Job search strategy (13)
Kidney disease (4)
Layoffs (14)
Legal (620)
Licensing (1)
Liver cancer (1)
Longevity (8)
Lung cancer (37)
Lymphoma (6)
Machine learning (5)
Management (1)
Manufacturing (51)
MASH (12)
Medical device (775)
Medtech (787)
Mergers & acquisitions (1981)
Metabolic disorders (32)
mRNA (9)
Multiple sclerosis (6)
NASH (4)
Netherlands (1)
Neurodegenerative disease (21)
Neuropsychiatric disorders (3)
Neuroscience (209)
NextGen: Class of 2026 (317)
Non-profit (135)
Now hiring (1)
Obesity (8)
Opinion (5)
Ovarian cancer (6)
Pain (17)
Pancreatic cancer (31)
Parkinson's disease (10)
Partnered (12)
Patents (41)
Patient recruitment (33)
Patient selection (4)
People (4773)
Pharmaceutical (4)
Phase 1 (1090)
Phase 2 (1713)
Phase 3 (978)
Pipeline (527)
Postmarket research (77)
Preclinical (542)
Press Release (2)
Prostate cancer (34)
Psychedelics (3)
Radiopharmaceuticals (33)
Rare diseases (68)
Real estate (299)
Recruiting (1)
Regenerative medicine (1)
Regulatory (1132)
Reports (25)
Research institute (125)
Rett syndrome (6)
RNA editing (5)
RSV (1)
Schizophrenia (9)
Series A (13)
Series B (8)
Service/supplier (2)
Sickle cell disease (2)
Spinal muscular atrophy (2)
Sponsored (3)
Startups (231)
State (1)
Supply chain (4)
Vaccines (35)
Venture capital (2)
Weight loss (3)
Women's health (4)
Date
Today (9)
Last 7 days (41)
Last 30 days (163)
Last 365 days (1880)
2026 (1567)
2025 (1946)
2024 (2323)
2023 (2646)
2022 (3480)
2021 (4144)
2020 (3302)
2019 (2295)
2018 (1816)
2017 (1758)
2016 (1686)
2015 (2039)
2014 (1633)
2013 (1343)
2012 (1500)
2011 (1454)
2010 (1539)
Location
Africa (41)
Alabama (2)
Arizona (15)
Asia (1702)
Australia (180)
California (622)
Canada (1305)
China (21)
Colorado (23)
Connecticut (8)
Delaware (16)
Europe (3859)
Florida (134)
Georgia (10)
Idaho (3)
Illinois (65)
India (6)
Indiana (59)
Iowa (2)
Japan (45)
Kansas (3)
Kentucky (4)
Louisiana (3)
Maryland (40)
Massachusetts (430)
Michigan (56)
Minnesota (85)
Montana (9)
Nebraska (3)
Nevada (21)
New Hampshire (11)
New Jersey (324)
New Mexico (7)
New York (301)
North Carolina (102)
North Dakota (3)
Northern California (351)
Ohio (23)
Oklahoma (4)
Oregon (1)
Pennsylvania (230)
Puerto Rico (1)
South America (55)
South Carolina (1)
Southern California (173)
Tennessee (11)
Texas (238)
United States (2850)
Utah (10)
Virginia (9)
Washington D.C. (2)
Washington State (46)
Wisconsin (45)
Wyoming (3)
44,239 Results for "zenith epigenetics corp".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Zenith Epigenetics Receives FDA Clearance for Registration Enabling Study of ZEN-3694 in NUT Carcinoma
October 8, 2026
·
5 min read
Press Releases
Zenith Capital Corp. Amends Promissory Notes
May 12, 2026
·
6 min read
Press Releases
Zenith Epigenetics Provides Update on ZEN-3694 NUT Carcinoma Program
April 9, 2026
·
5 min read
Press Releases
Zenith Capital Corp. Appoints Bryan Ede to Board of Directors
March 4, 2026
·
3 min read
Press Releases
FDA grants Zenith’s ZEN-3694 Fast Track Status
Zenith Epigenetics Announces Grant of U.S. Food and Drug Administration Fast Track Designation for ZEN-3694 in NUT Carcinoma
July 14, 2025
·
5 min read
Press Releases
Zenith Epigenetics’ ZEN-3694 Receives Orphan Drug Designation from FDA
October 27, 2025
·
6 min read
Zenith Epigenetics Proudly Supports Rare Disease Day
Zenith Epigenetics Ltd. (“Zenith” or the “Company”) announces its support of Rare Disease Day by highlighting our expanded development efforts of BET inhibitor ZEN-3694
February 29, 2024
·
5 min read
Zenith Epigenetics Ltd. Announces Collaboration with Cencora on ZEN-3694
Zenith Epigenetics Ltd. (“Zenith” or the “Company”), a global leader in epigenetics, announced today it has entered into an agreement with Cencora (formerly AmerisourceBergen) aimed at accelerating the commercialization of Zenith Epigenetics’ ZEN-3694 program.
October 26, 2023
·
7 min read
Press Releases
Zoghbi, Bird Honored for Work on Epigenetics in Neurological Diseases
September 2, 2026
·
4 min read
Press Releases
Chipscreen Biosciences Announces NMPA IND Approval for NW001, a PD-L1-Targeted Epigenetic Immune-Modulating Antibody Conjugate
October 18, 2026
·
4 min read
1 of 4,424
Next
